Keyphrases
Prostate Cancer
100%
Insulin-like Growth Factor 1 Receptor (IGF1R)
100%
Insulin-like
100%
Cancer Tumor
100%
In Vivo Effects
100%
Docetaxel
100%
Androgen-independent
30%
Tumor
30%
Prostate Cancer Model
20%
Tumor Inhibition
20%
Osseous
20%
Tumor Cells
10%
Tumor Growth
10%
Treatment Efficacy
10%
Apoptosis
10%
Survival Benefit
10%
Associated Genes
10%
Gene Expression Profile
10%
Negative Regulation
10%
Cell Survival
10%
Cell Cycle Progression
10%
Therapeutic Effect
10%
Advanced Prostate Cancer
10%
Total Prostate-specific Antigen
10%
Treatment Cessation
10%
Human Xenografts
10%
Vehicle Control
10%
Prostate Tumor
10%
Prostate Cancer Patients
10%
Hormone-sensitive Prostate Cancer
10%
Cell Cycle Regulation
10%
Severe Combined Immunodeficient Mice
10%
Xenograft Tumor Growth
10%
Induced Resistance
10%
Prostate Tumor Growth
10%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Somatomedin C
100%
Receptor Antibody
100%
Docetaxel
100%
Neoplasm
100%
Tumor Growth
50%
Androgen
40%
Cancer Model
20%
Prostate Tumor
20%
SCID Mouse
10%
Prostate Specific Antigen
10%
Therapeutic Effect
10%
Somatomedin C Receptor
10%
Combination Therapy
10%